NMPA Approval

Dalteparin Sodium Injection

Approval Number

国药准字J20171060

Registration Date

September 25, 2017

Previous Approval Numbers

H20170040

Drug Information

Generic Name

达肝素钠注射液

Trade Name

法安明

Dosage Form

注射剂

Strength

0.2ml: 5000IU

Drug Type

化学药品

Registration Date

September 25, 2017

Company Address

Boulevard de la Plaine 17, 1050 Bruxelles, Belgium

Company Address

Schützenstrasse 87, 99-101-88212 Ravensburg, Germany

Empowering clinical research with data-driven insights and AI-powered tools.

达肝素钠注射液 - NMPA 批准文号 | MedPath